SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001494650-23-000055
Filing Date
2023-06-09
Accepted
2023-06-09 14:03:27
Documents
1
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686333798.html 4  
1 FORM 4 wk-form4_1686333798.xml 4 3911
  Complete submission text file 0001494650-23-000055.txt   5311
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Issuer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Heyman Tomas J. (Reporting) CIK: 0001814673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38241 | Film No.: 231004766